Tags

Type your tag names separated by a space and hit enter

Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania.
Behav Pharmacol 2006; 17(4):311-8BP

Abstract

Pharmacological studies suggest that neurotrophins may play a role in the effects of lithium and valproate on mood regulation. In this study, we tested the hypotheses that lithium and valproate would reverse and prevent the behavioral and biochemical effects of amphetamine, using a rat model of mania. In the reversal treatment, male Wistar rats were first administered D-amphetamine or saline for 14 days, and then, between days 8-14, rats were treated with lithium, valproate or saline. In the prevention treatment, rats were pretreated with lithium, valproate or saline, and then, between days 8-14, rats were administered D-amphetamine or saline. Locomotor behavior was assessed using the open-field task and hippocampal nerve growth factor levels were determined by enzyme-linked immunosorbent assay. Both lithium and valproate reversed and prevented D-amphetamine-induced hyperactivity. Lithium increased nerve growth factor content in rat hippocampus in both experiments, but this effect was blocked with the co-administration of D-amphetamine. No significant effects on nerve growth factor levels were observed with valproate or D-amphetamine alone. These findings suggest that nerve growth factor may play a role in the neurotrophic effects of lithium but do not support the hypotheses that the nerve growth factor/TrkA pathway is involved in the pathophysiology of bipolar disorder.

Authors+Show Affiliations

Department of Biochemistry, ICBS, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

16914949

Citation

Frey, Benício N., et al. "Lithium Increases Nerve Growth Factor Levels in the Rat Hippocampus in an Animal Model of Mania." Behavioural Pharmacology, vol. 17, no. 4, 2006, pp. 311-8.
Frey BN, Andreazza AC, Rosa AR, et al. Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania. Behav Pharmacol. 2006;17(4):311-8.
Frey, B. N., Andreazza, A. C., Rosa, A. R., Martins, M. R., Valvassori, S. S., Réus, G. Z., ... Kapczinski, F. (2006). Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania. Behavioural Pharmacology, 17(4), pp. 311-8.
Frey BN, et al. Lithium Increases Nerve Growth Factor Levels in the Rat Hippocampus in an Animal Model of Mania. Behav Pharmacol. 2006;17(4):311-8. PubMed PMID: 16914949.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania. AU - Frey,Benício N, AU - Andreazza,Ana C, AU - Rosa,Adriane R, AU - Martins,Márcio R, AU - Valvassori,Samira S, AU - Réus,Gislaine Z, AU - Hatch,John P, AU - Quevedo,João, AU - Kapczinski,Flávio, PY - 2006/8/18/pubmed PY - 2006/9/16/medline PY - 2006/8/18/entrez SP - 311 EP - 8 JF - Behavioural pharmacology JO - Behav Pharmacol VL - 17 IS - 4 N2 - Pharmacological studies suggest that neurotrophins may play a role in the effects of lithium and valproate on mood regulation. In this study, we tested the hypotheses that lithium and valproate would reverse and prevent the behavioral and biochemical effects of amphetamine, using a rat model of mania. In the reversal treatment, male Wistar rats were first administered D-amphetamine or saline for 14 days, and then, between days 8-14, rats were treated with lithium, valproate or saline. In the prevention treatment, rats were pretreated with lithium, valproate or saline, and then, between days 8-14, rats were administered D-amphetamine or saline. Locomotor behavior was assessed using the open-field task and hippocampal nerve growth factor levels were determined by enzyme-linked immunosorbent assay. Both lithium and valproate reversed and prevented D-amphetamine-induced hyperactivity. Lithium increased nerve growth factor content in rat hippocampus in both experiments, but this effect was blocked with the co-administration of D-amphetamine. No significant effects on nerve growth factor levels were observed with valproate or D-amphetamine alone. These findings suggest that nerve growth factor may play a role in the neurotrophic effects of lithium but do not support the hypotheses that the nerve growth factor/TrkA pathway is involved in the pathophysiology of bipolar disorder. SN - 0955-8810 UR - https://www.unboundmedicine.com/medline/citation/16914949/Lithium_increases_nerve_growth_factor_levels_in_the_rat_hippocampus_in_an_animal_model_of_mania_ L2 - http://Insights.ovid.com/pubmed?pmid=16914949 DB - PRIME DP - Unbound Medicine ER -